EP1885339
Samsetningar af SRC/ABL tálma
Status:
EP Einkaleyfi ógilt eftir andmæliEP appl. date:
4.5.2006EP published:
29.7.2015EP application number:
06769997.5
EP translation filed:
14.9.2015Grant published:
15.10.2015EPO information:
European Patent Register
Max expiry date:
3.5.2026Expiry date:
3.5.2022
Title:
FORMULATIONS OF A SRC/ABL INHIBITOR
Timeline
Today
4.5.2006EP application
29.7.2015EP Publication
14.9.2015Translation submitted
15.10.2015Registration published
3.5.2022Expires
Owner
Name:
Bristol-Myers Squibb Holdings Ireland Unlimited CompanyAddress:
Hinterbergstrasse 16, 6312, Steinhausen, CH
Inventor
Name:
GAO, Julia ZHAddress:
Plainsboro, New Jersey, US
Name:
MOTHERAM, RajeshwarAddress:
Dayton, New Jersey, US
Agent
Name:
G.H. Sigurgeirsson ehf.Address:
Borgartúni 26, 105, Reykjavík,
Priority
Number:
678030 PDate:
5.5.2005Country:
US
Classification
Categories:
A61K 9/16, A61K 9/20, A61K 9/28, A61K 31/506
Annual fees
Number
Paid
Expires
Payer
Number: 11
Paid: 12.4.2016
Expires: 3.5.2017
Payer: Árnason Faktor
Number: 12
Paid: 10.4.2017
Expires: 3.5.2018
Payer: Árnason Faktor
Number: 13
Paid: 9.4.2018
Expires: 3.5.2019
Payer: Árnason Faktor
Number: 14
Paid: 5.4.2019
Expires: 3.5.2020
Payer: Árnason Faktor
Number: 15
Paid: 7.4.2020
Expires: 3.5.2021
Payer: Árnason Faktor ehf.
Number: 16
Paid: 8.4.2021
Expires: 3.5.2022
Payer: Árnason Faktor ehf.